Company

Golden Biotechnology Corp

Headquarters: New Taipei City, Taiwan

Employees: 122

TWSE: 4132 -1.99%

Market Cap

TW$3.97 Billion

TWD as of July 1, 2024

US$122.0 Million

Market Cap History

Golden Biotechnology Corp market capitalization over time

Evolution of Golden Biotechnology Corp market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Golden Biotechnology Corp

Detailed Description

Golden Biotechnology Corporation operates as a drug discovery and healthy food supplement manufacturing company in Taiwan, the United States, Japan, China, Korea, and Singapore. Its products include Liverty that is used for liver health support and fatigue; Rasle, an auto-immune adjuvant therapy; ZSAINO, a nourishment product for recovery from illness and for health improvement; and UMOOZE, a herbal formula for optimal health in males. The company also provides Antroquinonol, an anticancer molecule for the treatment of pancreatic cancer, acute myeloid leukemia, and hepatocellular carcinoma, as well as hypercholesterolemia and hyperlipidemia. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Golden Biotechnology Corp has the following listings and related stock indices.


Stock: TWSE: 4132 wb_incandescent

Details

Headquarters:

No. 27-6, Zhongzheng E. Road

15th Floor Section 2 Tamsui District

New Taipei City, 251

Taiwan

Phone: 886 2 2808 6006